The epidemiology, clinical findings and prognosis of XXXX in Iran.

@entity1 @entity6461 @entity4181 @entity3079 @entity417 @entity548 @entity5 @entity2580 @entity14 @entity4303 @entity320 @entity1487
UNASSIGNED: 9630 Background: This study was performed to evaluate the clinical features and outcome of @entity1 with @entity14 ( @entity14 ) in Iran. METHODS: All cases of @entity14 presented to a main countryside referral University hospital (SGH) for @entity5 in Teheran, Iran between June 20,2000 and January 3,2003 were retrospectively reviewed to determine age, gender, subsite distribution, early symptoms, ethnicity, type of the @entity14 and the chemotherapy management. RESULTS: A total of 200 @entity1 were included .114 @entity1 (57.0%) were male and 86 were female (43.0%) .Age ranged from 13-90 years with a mean of 55.15+/- 14.5 years.16.5% of @entity1 were below 40 years of age.The @entity5 were classified as : appendix (n=4), cecum ( n=7), Right Cancers (RC), from the cecum to hepatic flexure (n=1), hepatic flexure ( n=2), Transverse Colon (n=19), Splenic Flexure (n=3), Left Colon (LC) from the Splenic Flexure down to Sigmoid (n=6), Sigmoid ( n=16), Rectum ( n=117), Rectosigmoid _ Rectal lesions (n=16), and @entity14 without known locations (n=9). @entity3079 was the most common (n=181, 90%), followed by Mucinous AC (n=15), @entity6461 (n=1), @entity4303 (n=1), @entity320 (n=1), @entity2580 (n=1). The most common presenting symptom was @entity548 ( n=68, 34.5%) . 37% of @entity1 had @entity417 at the time of diagnosis. 130 of @entity1 underwent chemotherapy and the combination of @entity1487 and @entity4181 was predominanat. (n=104, 52%) Younger @entity1 significantly had more Mucinous AC (p=.008) and took more @entity1487 .(p=0.05) Conclusions: We have no reports from the Epidemiology of @entity14 in Iran since 1977. the data suggested a younger age distribution for @entity14 . we found no significant difference between age, gender and type of @entity5 with subsite distribution . Distal (left-sided) @entity14 was more prevalent. 30.5% of @entity1 were diagnosed by screening studies which highly suggests the procedure. 1 out of 200 @entity1 was ethnically Jews and because of high risk in these @entity1 with a population of 26,354 in a 61M in Iran, so more investigation is needed. @entity417 was less common in our population. younger @entity1 received medical attention and @entity1487 medication earlier and more. No significant financial relationships to disclose.
